Notably, among the biomarkers, only SFTPB was significantly associated with future ILD progression (odds ratio: 1.69, P = 0.042), though in multivariate analysis with %FVC, it was not (odds ratio: 1.41, P = 0.20) (Supplemental Table 8). The gene discussed is SFTPB; the disease is interstitial lung disease.